<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Aplastic anemia: Management in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Aplastic anemia: Management in adults</h1>
<div class="graphic"><div class="figure"><div class="ttl">Aplastic anemia: Management in adults</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm should be used together with related UpToDate topics for diagnosis and grading of disease severity, assessment of medical fitness, and management of AA in adults.</div><div class="graphic_footnotes"><p>AA: aplastic anemia; ATG: anti-thymocyte globulin; CsA: cyclosporine A; ECOG PS: Eastern Cooperative Oncology Group performance status; HCT: hematopoietic cell transplantation; TPO: thrombopoietin.</p>
<p>* Criteria for severe AA may vary among centers. Some patients who do not strictly meet these criteria may be considered to have severe AA.</p>
¶ Patients with moderate AA should be monitored for progression to severe AA; treatment is individualized and management should consider comorbid conditions.</div><div id="graphicVersion">Graphic 139782 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
